İncirli Sıla Usar, Taşkapilioğlu Özlem
Department of Neurology, Dr. Burhan Nalbantoglu State Hospital, Nicosia, North Cyprus.
Department of Neurology, Mehmet Ali Aydınlar Acıbadem University, School of Medicine, İstanbul, Turkey.
Noro Psikiyatr Ars. 2018;55(Suppl 1):S84-S87. doi: 10.29399/npa.23352.
Walking limitations play a key role in the development of disability in multiple sclerosis (MS) patients. Vast majority of patients, even in the very early stages of the disease, experience walking disturbances. Measuring capacity and performance in lower extremities enables us to 1) monitor disease pregression; 2) evaluate treatment responses; 3) determine the necessity of new treatment strategies on time. The purpose of this review is to highlight the importance of regular walking assessments in MS patients, give idea about which measurement tools to choose, and provide insight for future investigations in the light of new technological developments.
行走受限在多发性硬化症(MS)患者残疾的发展过程中起着关键作用。绝大多数患者,即使在疾病的早期阶段,也会出现行走障碍。测量下肢的能力和表现使我们能够:1)监测疾病进展;2)评估治疗反应;3)及时确定新治疗策略的必要性。本综述的目的是强调对MS患者进行定期行走评估的重要性,介绍应选择哪些测量工具,并根据新技术发展为未来的研究提供见解。